Digitale Diagnoseunterstützung seltener rheumatologischer Erkrankungen: Evidenz und Perspektiven
摘要
The diagnosis of rare rheumatic diseases is challenging due to their complex and often atypical symptoms. Diagnostic delays are often associated with significant consequences for morbidity and increased costs. Traditional digital diagnostic decision support systems (DDSS) have only been able to close this gap to a limited extent. Large language models (LLMs), on the other hand, differ fundamentally in how they work, as they can process free text, enable simple questions to be asked, and process multimodal information. There is growing evidence that LLMs appear to be superior to conventional DDSS in various areas. This review classifies the current evidence, discusses the benefits and risks in rheumatological care, and outlines the prerequisites for safe implementation in clinical workflows, including regulatory and ethical aspects.